Filters

Term Search
You can select from the dropdown list OR enter your own terms to refine the search.

Last Updated: 10/31/2025

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 755 publications

Evaluation of the efficacy and cost-effectiveness of safinamide versus rasagiline: a systematic review.

Evaluation of the efficacy and cost-effectiveness of safinamide versus rasagiline: a systematic review.

Journal: Journal of comparative effectiveness research
Published: August 14, 2025

Enantioselective Gram-Scale Synthesis of Rasagiline via Chiral Phosphoric Acid-Catalyzed Reduction of Cyclic Imine.

Enantioselective Gram-Scale Synthesis of Rasagiline via Chiral Phosphoric Acid-Catalyzed Reduction of Cyclic Imine.

Journal: Chemistry, an Asian journal
Published: July 29, 2025

Rasagiline Inhibits Human Melanoma Cell Viability and Interacts Synergistically with Mitoxantrone and Antagonistically with Cisplatin-In Vitro Isobolographic Studies.

Rasagiline Inhibits Human Melanoma Cell Viability and Interacts Synergistically with Mitoxantrone and Antagonistically with Cisplatin-In Vitro Isobolographic Studies.

Journal: Cancers
Published: July 11, 2025

Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study.

Add-on therapies to levodopa improve pain modulation in Parkinson's disease with motor fluctuations: A prospective cohort study.

Journal: Parkinsonism & related disorders
Published: June 24, 2025

Neuroprotective effects of chemical constituents from Nicotiana tabacum L. in Parkinson's disease.

Neuroprotective effects of chemical constituents from Nicotiana tabacum L. in Parkinson's disease.

Journal: Natural products and bioprospecting
Published: June 13, 2025

Comparative efficacy and safety of irreversible (rasagiline) and reversible (safinamide) monoamine oxidase inhibitors as add-on therapy for Parkinson's disease.

Comparative efficacy and safety of irreversible (rasagiline) and reversible (safinamide) monoamine oxidase inhibitors as add-on therapy for Parkinson's disease.

Journal: Journal of neurology
Published: May 26, 2025

Streamlined analytical strategy using resonance Rayleigh scattering signal amplification for nanoscale quantification of rasagiline in tablets with content assessment.

Streamlined analytical strategy using resonance Rayleigh scattering signal amplification for nanoscale quantification of rasagiline in tablets with content assessment.

Journal: BMC chemistry
Published: May 18, 2025

Rasagiline mesylate-based microneedle patches: A patient-friendly treatment regimen for Parkinson's disease.

Rasagiline mesylate-based microneedle patches: A patient-friendly treatment regimen for Parkinson's disease.

Journal: International journal of pharmaceutics
Published: May 09, 2025

Assessing neurological and cardiovascular effects caused by pharmaceuticals in river water: Insights from Daphnia magna and Danio rerio embryos.

Assessing neurological and cardiovascular effects caused by pharmaceuticals in river water: Insights from Daphnia magna and Danio rerio embryos.

Journal: Chemosphere
Published: April 30, 2025

Exploring Fatigue in Parkinson's Disease: A Comprehensive Literature Review.

Exploring Fatigue in Parkinson's Disease: A Comprehensive Literature Review.

Journal: Cureus
Published: March 24, 2025

The "Wearing Off" Phenomenon for Rasagiline, Entacapone, Carbidopa, and Levodopa in the Setting of Parkinson's Disease.

The "Wearing Off" Phenomenon for Rasagiline, Entacapone, Carbidopa, and Levodopa in the Setting of Parkinson's Disease.

Journal: HCA healthcare journal of medicine
Published: March 12, 2025

Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor.

Design of Benzyl-triazolopyrimidine-Based NADPH Oxidase Inhibitors Leads to the Discovery of a Potent Dual Covalent NOX2/MAOB Inhibitor.

Journal: Journal of medicinal chemistry
Published: March 05, 2025
Showing 1-12 of 755

Last Updated: 10/31/2025